Professional Documents
Culture Documents
Genetic/congenital
Riley-Day syndrome
Renal hypercalciuria
Osteogenesis imperfecta
Cystic fibrosis
Hemochromatosis
Ehlers-Danlos syndrome
Homocystinuria
Glycogen storage disease
Hypophosphatasia
Gaucher disease
Idiopathic hypercalciuria
Marfan syndrome
Porphyria
Menkes steely hair
Hypogonadal states
syndrome
Hypogonadal states
Androgen insensitivity
Panhypopituitarism
Anorexia nervosa/bulimia nervosa Premature menopause
Female athlete triad Turner syndrome
Hyperprolactinemia Klinefelter syndrome
Endocrine disorders
Cushing syndrome
Hyperparathyroidis
Diabetes mellitus m Hyperthyroidism
Acromegaly Hypogonadism
Adrenal insufficiency Pregnancy
Estrogen deficiency Prolactinoma
Deficiency states
Calcium deficiency
Magnesium deficiency Gastrectomy
Protein deficiency Malabsorption
Vitamin D deficiency Malnutrition
Bariatric surgery Parenteral nutrition
Celiac disease Primary biliary cirrhosis
Inflammatory diseases
Inflammatory bowel disease
Ankylosing spondylitis Rheumatoid arthritis
Systemic lupus erythematosus
Hematologic and neoplastic disorders
Hemochromatosis
Hemophilia Sickle cell anemia
Leukemia Systemic mastocytosis
Lymphoma Thalassemia
Multiple myeloma Metastatic disease
Medications
Anticonvulsants
Antipsychotic drugs Furosemide
Antiretroviral drugs Glucocorticoids and corticotropin
Aromatase inhibitors Heparin (long term)
Chemotherapeutic/transplant Hormonal/endocrine therapies: gonadotropin-
drugs: cyclosporine, releasing hormone (GnRH) agonists, luteinizing
tacrolimus, platinum hormone-releasing hormone (LHRH)
compounds, analogues, depomedroxyprogesterone,
cyclophosphamide, excessive thyroxine
ifosfamide, high-dose Lithium
methotrexate Selective serotonin reuptake inhibitors (SSRIs)
Miscellaneous
Alcoholism
Amyloidosis Idiopathic scoliosis
Chronic metabolic acidosis Immobility
Congestive heart failure Multiple sclerosis
Depression Ochronosis
Emphysema Organ transplantation
Chronic or end-stage renal disease Pregnancy/lactation
Chronic liver disease Sarcoidosis
HIV/AIDS Weightlessness
Risk
factors
Advanced age (≥50 years) Physical inactivity or immobilization
Female sex Use of certain drugs (eg,
White or Asian ethnicity anticonvulsants, systemic steroids,
Genetic factors, such as a family thyroid supplements, heparin,
history of osteoporosis chemotherapeutic agents, insulin)
Thin build or small stature, eg, body Alcohol and tobacco use
weight less than 127 lb, (57.7 kg) Androgen or estrogen deficiency
Amenorrhea Calcium deficiency
Late menarche Dowager hump
Early menopause
Postmenopausal
state
A potentially useful mnemonic for osteoporotic risk
factors is OSTEOPOROSIS, as follows:
• L O w calcium intake
• S eizure meds (anticonvulsants)
• T hin build
• E thanol intake
• Hyp O gonadism
• P revious fracture
• Thyr O id excess
• R ace (white, Asian)
• O ther relatives with osteoporosis
• S teroids
• I nactivity
• S moking
Epidemiology
• Women age 65 years and older and men age 70 years and
older, regardless of clinical risk factors
• Postmenopausal women and men above age 50–69, based
alpha-hydroxylase
on risk factor profile
• Postmenopausal women and men age 50 and older who
have had an adult-age fracture, to diagnose and determine
the degree of osteoporosis
• Vertebral imaging is recommended for the
following patients:
• All women age 70 and older and all men age 80 and older
whose BMD T-score at the spine, total hip, or femoral neck
is –1.0 or lower
• All women age 65 to 69 and all men age 70-79 whose BMD
T-score at the spine, total hip, or femoral neck is –1.5 or
lower
• Vertebral imaging is also recommended for
postmenopausal women and men age 50 and older with
the following specific risk factors:
• Low-trauma fractures
• Height loss of 1.5 inches (4 cm) or more since peak height at
age 20
• Height loss of 0.8 inches (2 cm) or more since a previously
documented height measurement
• Recent or ongoing long-term glucocorticoid treatment
• Other plain radiography features and recommended as follows:
- Obtain radiographs of the affected area in symptomatic patients
-Lateral spine radiography can be performed in asymptomatic
patients in whom a vertebral fracture is suspected; a scoliosis
series is useful for detecting occult vertebral fractures
-Radiographic findings can suggest the presence of osteopenia,
or bone loss, but cannot be used to diagnose osteoporosis
-Radiographs may also show other conditions, such as
osteoarthritis, disk disease, or spondylolisthesis
Diagnostic Considerations
• Osteomalacia
• Leukemia
• Lymphoma
• Metastases (bony and other)
• Pathologic fractures secondary to bone metastases from
cancer
• Pediatric osteogenesis imperfecta
• Renal osteodystrophy
Differential
Diagnoses
• Homocystinuria/Homocysteinemia
• Hyperparathyroidism
• Imaging in Osteomalacia and Renal Osteodystrophy
• Mastocytosis
• Multiple Myeloma
• Paget Disease
• Scurvy
• Sickle Cell Anemia
Complication
•
s
Vertebral compression fractures often occur with minimal
stress, such as coughing, lifting, or bending.
• Hip fractures are the most devastating and occur most
commonly at the femoral neck and intertrochanteric regions.
• Secondary complications of hip fractures include nosocomial
infections and pulmonary thromboembolism.
• Increased morbidity and mortality secondary to vertebral
compression fractures and hip fractures.
• Spinal deformities and a dowager's hump, and they may lose
1-2 inches of height by their seventh decade of life
Prognosi
s
The prognosis for osteoporosis is good if bone loss is
detected in the early phases and proper intervention is
undertaken.
• Effect of fractures on prognosis
- Vertebral compression fractures are associated with
increased morbidity and mortality rates.
- Hip fractures, More than 250,000 hip fractures are
attributed to osteoporosis each year, they are associated
with significantly increased morbidity and mortality rates in
men and women.
Osteoporosis Workup
Approach
Considerations
• Laboratory studies to establish baseline values and to
look for potential secondary causes of osteoporosis
• Measurement of bone mineral density (BMD) to assess
bone loss and estimate the risk of fracture
• Bone biopsy may be indicated in specific situations.
Laboratory
Studies
CBC results may reveal anemia, as in sickle cell disease, and may
raise the suspicion for alcohol abuse
Serum tryptase
Help identify mastocytosis
urine N-methylhistamine
When a hematologicdisorder is
Bone marrow biopsy suspected
• Biochemical Markers of Bone Turnover
• Biochemical markers of bone turnover reflect bone
formation or bone resorption.
• These markers (both formation and resorption) may be
elevated in high-bone-turnover states (eg, early
postmenopausal osteoporosis) and may be useful in some
patients for monitoring early response to therapy.
A summary list of Biochemical Markers of Bone
Turnover
Bone formation markers Bone resorption markers
Serum total alkaline phosphtase Urinary hydroxyproline
Serum bone–specific alkaline Urinary total pyridinoline
phosphatase Urinary free deoxypyridinoline
Serum osteocalcin Urinary collagen type 1
Serum type 1 procollagen Urinary or serum collagen type 1
Bone sialoprotein
Tartrate-resistant acid
phosphatase
Plain
•Radiography
.
Plain radiography is
recommended to assess
overall skeletal integrity.
In particular, in the workup
for osteoporosis, plain
radiography may be
indicated if a fracture is
already suspected or if
patients have lost more
than 1.5 inches of height Asymmetric loss in vertebral
body height with kyphosis
Lateral spine radiography can be
performed in asymptomatic
patients in whom a vertebral
fracture is suspected, in those
with height loss in the absence of
other symptoms, or in those
with pain in the thoracic or
upper lumbar spine .
A scoliosis series is useful for
detecting occult vertebral
Severe osteoporosis.
fractures. multiple vertebral crush fractures
• Radiographic findings can suggest the presence of
osteopenia, or bone loss, but cannot be used to diagnose
osteoporosis.
• Osteopenia is suggested by a cortical width that is less than
the medullary width.
• Plain radiography is not as accurate as BMD testing.
Because osteoporosis predominantly affects trabecular
bone rather than cortical bone, radiography does not reveal
osteoporotic changes until they affect the cortical bone.
Intertrochanteric Fracture. Subtrochanteric Fracture. This occurs
even further down the bone and may be
This occurs further down the bone
broken into several pieces.
Dual-Energy X-Ray Absorptiometry
(DXA)
DXA is currently
the criterion
standard for the
evaluation of
BMD.
DXA is used to
calculate BMD
at the lumbar
spine, hip, and
proximal
femur
• DXA provides the patient’s T-score, which is the BMD value
compared with that of control subjects who are at their peak
BMD.
• World Health Organization (WHO) criteria define a normal T-
score value as within 1 standard deviation (SD) of the mean
BMD value in a healthy young adult.
• Values lying farther from the mean are stratified as follows:
- T-score of –1 to –2.5 SD indicates osteopenia
- T-score of less than –2.5 SD indicates osteoporosis
-T-score of less than –2.5 SD with fragility fracture(s) indicates
severe osteoporosis
• DXA also provides the patient’s Z-score, which reflects a value
compared with that of persons matched for age and sex.
• Z-scores adjusted for ethnicity or race should be used in the
following patients:
• Premenopausal women
• Men younger than 50 years
• Children
• Z-score values of –2.0 SD or lower are defined as "below the
expected range for age" and those above –2.0 SD as "within the
expected range for age." The diagnosis of osteoporosis in these
groups should not be based on densitometric criteria alone.
WHO Definition of Osteoporosis Based on BMD Measurements by DXA
Definition Bone Mass Density Measurement T-Score
BMD within 1 SD of the mean
Normal bone density for young adult women T-score ≥ –1
Low bone mass BMD 1–2.5 SD below the mean for T-score between –1
(osteopenia) young-adult women and –2.5
Osteoporosis BMD ≥2.5 SD below the normal mean T-score ≤ –2.5
for young-adult women
BMD ≥2.5 SD below the normal mean
Severe or for young-adult women in a patient
T-score ≤ –2.5 (with
“established who has already experienced ≥1 fragility fracture[s])
” fractures
osteoporosis
Magnetic Resonance Imaging
• Physical therapy
-Physical therapy focuses on improving a patient's strength,
flexibility, posture, and balance to prevent falls and maximize
physical function.
-Postural retraining is key in this population. Spinal bone
mineral density (BMD) is directly correlated with the
strength of the back extensors; therefore, maintaining and
strengthening the back extensors should be emphasized.
Occupational therapy
• Training in the performance of activities of daily living
(ADLs) and in the proper use of adaptive equipment are
essential to the prevention of future falls.
• Home modification focuses on reducing the risk of falling by
installing handrails and grab bars in hallways, stairs, and
bathrooms.
• The use of a shower chair, tub bench, and adaptive bathing
devices also can be beneficial.
• The application of nonskid tape to steps (indoors and
outdoors), as well as the removal of throw rugs, greatly
improves home safety.
Exercise
• Aerobic low-impact exercises, such as walking and bicycling,
generally are recommended. During these activities, ensure
that the patient maintains an upright spinal alignment.
• Proper therapy for osteoporosis includes 3-5 sessions per week
of weight-bearing exercises, such as walking or jogging, with
each session lasting 45-60 minutes. The patient should be
instructed in a home-exercise program that incorporates the
necessary elements for improving posture and overall physical
fitness.
• The physical therapist must address balance training, because
fall prevention is important in eliminating the complication of
fracture.
Prevention of Osteoporosis
Email:
dr.hishamdabbagh@gmail.com
Email: haldabag@moh.gov.sa
Mobile: 00966536715868